Clinical trial
The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase
NCT02755337 is registered in ClinicalTrials.gov with Dr. Soetomo General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase
- Lead sponsor
- Dr. Soetomo General Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2016
- Completion date
- December 31, 2016
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-small-cell lung cancer